AMICUS THERAPEUTICS, INC. Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMICUS THERAPEUTICS, INC. for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Sell | S | 10.35 | 22,100 | 228,642 | 185,350 | 207.5 K to 185.4 K (-10.65 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 10.35 | 20,720 | 214,359 | 156,473 | 177.2 K to 156.5 K (-11.69 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.35 | 5,064 | 52,388 | 370,520 | 375.6 K to 370.5 K (-1.35 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 202,485 | |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.35 | 100,000 | 1,034,790 | 958,339 | 1.1 M to 958.3 K (-9.45 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 1,058,339 | 1 M to 1.1 M (+1.93 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 9.46 | 18,728 | 177,167 | 207,450 | 226.2 K to 207.5 K (-8.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 40,828 | 0 | 226,178 | 185.4 K to 226.2 K (+22.03 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 9.46 | 18,728 | 177,167 | 207,450 | 226.2 K to 207.5 K (-8.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.46 | 12,065 | 114,135 | 190,422 | 202.5 K to 190.4 K (-5.96 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 40,828 | 0 | 226,178 | 185.4 K to 226.2 K (+22.03 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 24,496 | 0 | 202,487 | 178 K to 202.5 K (+13.76 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.46 | 12,065 | 114,135 | 190,422 | 202.5 K to 190.4 K (-5.96 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 24,496 | 0 | 202,487 | 178 K to 202.5 K (+13.76 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.46 | 18,904 | 178,832 | 521,155 | 540.1 K to 521.2 K (-3.50 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 40,828 | 0 | 540,059 | 499.2 K to 540.1 K (+8.18 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.46 | 18,904 | 178,832 | 521,155 | 540.1 K to 521.2 K (-3.50 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.46 | 64,264 | 607,937 | 1,038,339 | 1.1 M to 1 M (-5.83 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 40,828 | 0 | 540,059 | 499.2 K to 540.1 K (+8.18 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 163,313 | 0 | 1,102,603 | 939.3 K to 1.1 M (+17.39 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.46 | 64,264 | 607,937 | 1,038,339 | 1.1 M to 1 M (-5.83 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.46 | 29,492 | 278,994 | 375,584 | 405.1 K to 375.6 K (-7.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 163,313 | 0 | 1,102,603 | 939.3 K to 1.1 M (+17.39 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 59,881 | 0 | 405,076 | 345.2 K to 405.1 K (+17.35 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.46 | 29,492 | 278,994 | 375,584 | 405.1 K to 375.6 K (-7.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 59,881 | 0 | 405,076 | 345.2 K to 405.1 K (+17.35 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.46 | 20,108 | 190,222 | 177,193 | 197.3 K to 177.2 K (-10.19 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 40,828 | 0 | 197,301 | 156.5 K to 197.3 K (+26.09 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.46 | 20,108 | 190,222 | 177,193 | 197.3 K to 177.2 K (-10.19 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 40,828 | 0 | 197,301 | 156.5 K to 197.3 K (+26.09 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 3.32 | 20,000 | 66,400 | 0 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 10.00 | 20,000 | 200,000 | 22,064 | 42.1 K to 22.1 K (-47.55 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 3.32 | 20,000 | 66,400 | 42,064 | 22.1 K to 42.1 K (+90.65 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 2,500 | 14,900 | 20,000 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 2,500 | 25,025 | 345,195 | 347.7 K to 345.2 K (-0.72 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 2,500 | 14,900 | 347,695 | 345.2 K to 347.7 K (+0.72 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 4.38 | 1,200 | 5,256 | 7,550 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.52 | 9,822 | 24,751 | 0 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 4.38 | 1,200 | 5,256 | 177,991 | 176.8 K to 178 K (+0.68 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.52 | 9,822 | 24,751 | 176,791 | 167 K to 176.8 K (+5.88 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Sell | S | 9.93 | 15,000 | 148,952 | 166,969 | 182 K to 167 K (-8.24 %) |
| Jan 08 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 9.36 | 9,938 | 92,980 | 156,473 | 166.4 K to 156.5 K (-5.97 %) |
| Jan 08 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 9.28 | 6,836 | 63,415 | 166,411 | 173.2 K to 166.4 K (-3.95 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.18 | 19,994 | 183,545 | 939,290 | 959.3 K to 939.3 K (-2.08 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.18 | 13,973 | 128,272 | 345,195 | 359.2 K to 345.2 K (-3.89 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.55 | 12,161 | 116,138 | 359,168 | 371.3 K to 359.2 K (-3.27 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Option Exercise | A | 9.55 | 91,439 | 873,242 | 91,439 | |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Payment of Exercise | F | 9.55 | 5,612 | 53,595 | 153,728 | 159.3 K to 153.7 K (-3.52 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Grant | A | 0.00 | 58,179 | 0 | 159,340 | 101.2 K to 159.3 K (+57.51 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Option Exercise | A | 9.55 | 15,127 | 144,463 | 15,127 | |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Payment of Exercise | F | 9.55 | 553 | 5,281 | 20,489 | 21 K to 20.5 K (-2.63 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Grant | A | 0.00 | 9,625 | 0 | 21,042 | 11.4 K to 21 K (+84.30 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.18 | 5,305 | 48,700 | 181,969 | 187.3 K to 182 K (-2.83 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.55 | 7,113 | 67,929 | 187,274 | 194.4 K to 187.3 K (-3.66 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 9.18 | 8,980 | 82,436 | 185,350 | 194.3 K to 185.4 K (-4.62 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 9.55 | 7,002 | 66,869 | 194,330 | 201.3 K to 194.3 K (-3.48 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.18 | 9,330 | 85,649 | 499,231 | 508.6 K to 499.2 K (-1.83 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.55 | 7,067 | 67,490 | 508,561 | 515.6 K to 508.6 K (-1.37 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.18 | 9,642 | 88,514 | 173,247 | 182.9 K to 173.2 K (-5.27 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.55 | 6,633 | 63,345 | 182,889 | 189.5 K to 182.9 K (-3.50 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 9.55 | 96,818 | 924,612 | 96,818 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 9.55 | 9,753 | 93,173 | 189,522 | 199.3 K to 189.5 K (-4.89 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 61,601 | 0 | 199,275 | 137.7 K to 199.3 K (+44.74 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.74 | 10,826 | 105,445 | 137,674 | 148.5 K to 137.7 K (-7.29 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 9.55 | 107,575 | 1,027,341 | 107,575 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 68,446 | 0 | 515,628 | 447.2 K to 515.6 K (+15.31 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.74 | 10,219 | 99,533 | 447,182 | 457.4 K to 447.2 K (-2.23 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | A | 9.55 | 112,954 | 1,078,711 | 112,954 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 71,868 | 0 | 194,387 | 122.5 K to 194.4 K (+58.66 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.74 | 6,735 | 65,599 | 122,519 | 129.3 K to 122.5 K (-5.21 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 7,500 | 44,700 | 22,500 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 9.55 | 188,257 | 1,797,854 | 188,257 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.61 | 7,500 | 72,039 | 359,140 | 366.6 K to 359.1 K (-2.05 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 7,500 | 44,700 | 366,640 | 359.1 K to 366.6 K (+2.09 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.56 | 14,627 | 139,850 | 359,140 | 373.8 K to 359.1 K (-3.91 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 119,780 | 0 | 373,767 | 254 K to 373.8 K (+47.16 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.74 | 15,556 | 151,515 | 253,987 | 269.5 K to 254 K (-5.77 %) |